Treatment with infliximab for a child with Behçet's disease
- 15 August 2003
- journal article
- case report
- Published by Wiley in Arthritis Care & Research
- Vol. 49 (4) , 599-600
- https://doi.org/10.1002/art.11204
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor alpha antibodyGut, 2001
- Remission of Behçet's syndrome with tumour necrosis factor α blocking therapyAnnals of the Rheumatic Diseases, 2001
- Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case reportGastroenterology, 2001
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Behçet's DiseaseNew England Journal of Medicine, 1999
- Thalidomide and derivatives: immunological investigations of tumour necrosis factor-alpha (TNF-α) inhibition suggest drugs capable of selective gene regulationClinical and Experimental Immunology, 1997
- Role of γδ T lymphocytes in the development of Behc¸et's diseaseClinical and Experimental Immunology, 1997
- Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functionsCytokine, 1995
- The Mouse/Human Chimeric Monoclonal Antibody cA2 Neutralizes TNF In Vitro and Protects Transgenic Mice from Cachexia and TNF Lethality In VivoCytokine, 1995
- Inhibition of endogenous TNF formation by pentoxifyllineImmunobiology, 1993